Why Consider a Clinical Trial for Acute Myeloid Leukemia?

HealthTree University: AML Clinical Trials

Clinical trials are a major part of treatment for many people with AML. According to AML experts, clinical trials should be considered at each phase of treatment because they have the potential to provide more effective therapies or combination of therapies than the current standard of care. We've assembled this HealthTree University unit which features top AML experts answering questions about AML clinical trials to teach you about how to understand trials, how to find trials and why trials can be beneficial to you.

11.01 - What are clinical trials?

11.02 - What is the difference between phase 1, 2 and 3 trials?

11.03 - What does FDA approved mean?

11.04 - At what point in a patient's care should the conversation about clinical trials start?

11.05 - What are the broad categoeries of clinical trials currently underway for MDS and AML?

11.06 - Why is participation in a clinical trial advantageous?

11.07 - What should a patient consider discussing with their provider when contemplating trials?

11.08 - How can patients learn more about clinical trials that are available? 

11.09 - Are there clinical trials available at every stage of AML?

11.10 - What is being tested in phase 1 clinical trials?

11.11.- What is the care like when participating in a clinical trial?

We'd like to thank our faculty who donated their time in creating these videos, including:

• Srinivasa Sanikommu, MD of Levine Cancer Institute
• Joseph Jurcic, MD of Columbia University

Want More?

We have over 100 HealthTree University videos online at HealthTree University. Learn the basics (and not-so-basics) of AML from some of the top AML doctors in the world! Completed units include:

• AML Basics 
• AML Genetics
• Building Your Healthcare Team
• AML Drug Classes
• Allogeneic Stem Cell Transplant
• Palliative Care

Visit HealthTree University